Dyne Therapeutics Statistics
NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.50-0.53 (-3.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Dyne Therapeutics by the numbers
Dyne Therapeutics has a market capitalization of $2.90 billion based on 187.39M shares outstanding. With trailing EPS of $-3.62, Dyne Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.4% below its 50-day average and 19.6% below its 200-day average.
Average daily trading volume is 2.94M shares, or about $45.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DYN valuation vs. peer median
| Metric | DYN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.90B | $3.02B | -4% |
| Avg. volume | 2.94M | 3.01M | -3% |
Peer median across 8 companies: ACAD, LEGN, TLX, SLS, BHC, XERS, VKTX, ABCL.
Valuation
- Market cap
- $2.90B
- EPS (TTM)
- $-3.62
- Shares outstanding
- 187.39M
Price and trading
- Previous close
- 16.03
- Open
- 15.91
- Day range
- 15.41 – 16.48
- 52-week range
- 14.00 – 27.31
- 52-week change
- -26.82%
- Beta
- —
- Volume
- 2.23M
- Average volume
- 2.94M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.90B
- Forward Pe
- -4.30
- Eps
- -3.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.31
- Week52 Low
- 14.00
- Avg Volume
- 2.94M
- Shares Outstanding
- 187.39M
- Ma50
- 16.55
- Ma200
- 19.27
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -43.23%
- Pct From52w Low
- 10.71%